Biomerica Inc

Biomerica Inc (BMRA) is a micro‑cap company focused on in‑vitro diagnostic products and related technologies. The business historically develops and sells assay kits and point‑of‑care tests for clinical and research use, with a product focus that has included gastrointestinal markers and other health diagnostics. With a market capitalisation in the single‑digit millions, it is a small, thinly traded company where revenues and margins may show volatility. Key considerations for investors include limited liquidity, small scale relative to industry peers, regulatory and reimbursement risks, and dependence on successful commercial adoption or partnerships. The company may offer upside if its tests gain traction or if it becomes attractive for a strategic buyer, but performance can be uneven and speculative. This summary is for educational purposes only and not personalised investment advice — values can rise and fall and past performance is not a reliable guide to future returns.